Screening for CVI in Angelman syndrome

A new study at Boston Children’s Hospital aims to better understand the prevalence of Cerebral Visual Impairment (CVI) in individuals with Angelman syndrome. CVI affects how the brain processes visual information and has been linked to epilepsy and other neurodevelopmental disorders.

This study is open to caregivers of individuals with Angelman syndrome of all ages and subtypes, with or without a CVI diagnosis.

Eligibility

• Be the parent or caregiver of an individual who is diagnosed with AS
• Be willing to participate in a one-time virtual visit lasting about 30 minutes
• Answer questions about your child’s visual health and behaviors

After participation, you will receive your individual’s CVI screening results.

Interest Form

Complete the interest form now

More information

Questions can be directed to emma.bauschard@childrens.harvard.edu.

See a flyer